Silent aspiration in Parkinson's disease patients with diurnal sialorrhea

被引:27
|
作者
Nobrega, Ana Caline [1 ]
Rodrigues, Bernardo [1 ]
Melo, Ailton [1 ]
机构
[1] Univ Fed Bahia, Div Neurol & Epidemiol, BR-41170290 Salvador, BA, Brazil
关键词
silent aspiration; Parkinson's disease; dysphagia; sialorrhea;
D O I
10.1016/j.clineuro.2007.09.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: We studied the frequency of silent laryngeal penetration or silent aspiration (SLP/SA) in Parkinson's disease (PD) patients with diurnal sialorrhea. Patients and methods: In 19 consecutive PD patients with diurnal sialorrhea, swallow was evaluated using the videofluoroscopy analysis. Data were analysed to determine the frequency of aspiration and its relationship with the severity of sialorrhea. Results: All patients were classified in the Hoehn and Yahr stages between 2 and 5. SLP/SA was observed in 21% of patients and the score of sialorrhea in the group with SLP/SA was 8.0 +/- 0.81, while in the group with no SLP/SA was 6.46 +/- 1.06 (p =0.02). Conclusion: SLP/SA is a frequent morbidity in PD patients, its risk is higher in later stages of disease and in those patients with severe sialorrhea. However, prospective and controlled studies of follow up will be necessary to determine the prognosis and management in this group of patients. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:117 / 119
页数:3
相关论文
共 50 条
  • [21] Dihydroergotoxine mesylate for the treatment of sialorrhea in Parkinson's disease
    Cheng, Yong-Qing
    Ge, Nian-Nian
    Zhu, Hong-Hong
    Sha, Zhi-Tao
    Jiang, Teng
    Zhang, Ying-Dong
    Tian, You-Yong
    PARKINSONISM & RELATED DISORDERS, 2019, 58 : 70 - 73
  • [22] Rimabotulinumtoxin B for the treatment of sialorrhea in Parkinson's disease
    Alvarez, M. V.
    Grogan, P. M.
    Alvarez, M.
    MOVEMENT DISORDERS, 2013, 28 : S92 - S93
  • [23] Effects of Repeated Botulinum Toxin Treatment for Sialorrhea in Patients with Parkinson's Disease
    Sen, Aysu
    Arpaci, Baki
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2015, 52 (01): : 69 - 72
  • [24] Glycopyrrolate as inhalation for treating sialorrhea in Parkinson's Disease
    Velzen, L.
    Masselink, J.
    Dorresteijn, L.
    Movig, K.
    MOVEMENT DISORDERS, 2019, 34 : S667 - S668
  • [25] Sialorrhea: Validation of a method for objective measurement and a clinical scale in Parkinson's disease patients
    Lloret, SP
    Gabriel, PA
    Nemet, ML
    Merello, M
    MOVEMENT DISORDERS, 2005, 20 : S99 - S99
  • [26] Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson's Disease: A Systematic Review
    Antonio Ruiz-Roca, Juan
    Pons-Fuster, Eduardo
    Lopez-Jornet, Pia
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (03):
  • [27] The treatment of sialorrhea with botulinum toxin (BTXA) in Parkinson's disease
    Panisset, M.
    Spevack, L.
    Wiseman, M.
    MOVEMENT DISORDERS, 2007, 22 : S83 - S83
  • [28] Sialorrhea in Parkinson's disease: a dysautonomic symptom often forgotten
    Manso Calderon, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 753 - 753
  • [29] Botulinum toxin type a in the treatment of sialorrhea in Parkinson's disease
    Santamato, Andrea
    Ianieri, Giancarlo
    Ranieri, Maurizio
    Megna, Marisa
    Panza, Francesco
    Fiore, Pietro
    Megna, Gianfranco
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : 765 - 767
  • [30] Ipratropium bromide spray as a treatment for sialorrhea in Parkinson's disease
    Fox, S.
    Thomsen, T.
    Asante, A.
    Galpern, W.
    MOVEMENT DISORDERS, 2006, 21 : S573 - S574